Illumina and Deerfield link arms to drive ‘genomics-first’ drug discovery

After years of partnering with the pharma industry, Illumina is now making its own foray into drug discovery. The DNA sequencing company is entering a 5-year collaboration with Deerfield Management to use its genomic tools and AI-driven platform to identify new therapeutic targets and bend the curve on high failure…

Click here to view original post